January 2, 2013 / 8:46 AM / 5 years ago

BRIEF-Silence Therapeutics appoints chief medical officer

LONDON, Jan 2 (Reuters) - Silence Therapeutics PLC : * Appointment of chief medical officer * appointed Michael Khan to oversee Phase II clinical trials

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below